Premium Information is available for this item - Upgrade for $1 a day
6760-01-584-3647
White Exposure Balancing System
6760015843647 015843647 MSCCPP PASSPORT
January 2023
2
Marketplace 6760-01-584-3647
Request a Quotation from participating marketplace vendors
Related Documents 6760-01-584-3647 5+ Documents (More...)
Control Consultants in Port Richey, FL United States https//www.nsnlookup.com /fsg-67/fsc-6760/us 6760-01-584-3647
White Exposure Balancing System 015843647 your Account Upgrade 6760-01-584-3647White Exposure Balancing
Restrictions 6760-01-584-3647
6760-01-584-3647 is a White Exposure Balancing System that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item is not suspected to be hazardous. This item does not contain a precious metal.
End Users 6760-01-584-3647
- Italy (ZR01)
- Effective Date:
- 1 Apr 2010
Approved Sources 6760-01-584-3647
- Part Number
- Manufacturer
- Status
- MSCCPP
- Manufacturer
- 56573 - X-Rite Global, Incorporated (Active)
- Primary Buy
- Primary Buy
- PASSPORT
- 56573 - X-Rite Global, Incorporated (Active)
- Secondary Buy
- Secondary Buy
Datasheet 6760-01-584-3647
- Characteristic
- Specifications
- FIIG
- Specifications
- A23900
- Part Name Assigned By Controlling Agency [CXCY]
- Color Checker Passport
- Special Features [FEAT]
- Includes Creative Enhancement Target, Classic Target, White Balance Target, Protective Pocket Size Case, Camera Calibration Software
NATO Stock Numbers Related to 6760-01-584-3647
Freight Information 6760-01-584-3647
6760-01-584-3647 has freight characteristics.. 6760-01-584-3647 has a variance between NMFC and UFC when transported by rail and the description should be consulted.